CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice

被引:34
作者
Weeratna, RD
Millan, CLB
McCluskie, MJ
Davis, HL
机构
[1] Coley Pharmaceut Canada, Ottawa, ON K1Y 4E9, Canada
[2] Ottawa Hosp, Loeb Hlth Res Inst, Ottawa, ON, Canada
来源
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY | 2001年 / 32卷 / 01期
关键词
immunization; vaccine adjuvant; Th bias; CpG dinucleotide; alum;
D O I
10.1016/S0928-8244(01)00267-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Induction of an appropriate immune response is essential for successful immunization. For example, Th1 type immune responses are necessary for the control of intracellular infections whereas Th2 type responses are more useful for the control of extracellular infections. Immunostimulatory CpG ODN (oligonucleotides containing unmethylated cytosine and guanine dinucleotides in specific base contexts) act as potent adjuvants and have been shown to induce Th1 type immune responses with a number of different antigens. This study investigates the effect of CpG ODN on the Th bias of immune responses generated against the hepatitis B major surface antigen (HBsAg) in adult (6 8 weeks old) and young ( < 1 week old) BALB/c mice. It also investigates the potential of CpG DNA to reverse a pre-established Th2 response generated as an adult or as a neonate, following re-exposure to HBsAg in adult life. Both adult and young mice immunized with HBsAg/ CpG ODN had a Th1 biased immune response (strong cytotoxic T-lymphocyte (CTL) induction, IgG2a much greater than IgG1). In contrast, mice immunized with HBsAg/alum had a Th2 type immune response (poor CTL, IgG1 much greater than IgG2a). More importantly, when animals were immunized with HBsAg/alum and boosted with HBsAg/CpG ODN, the CpG ODN were able to re-direct the Th2 response pre-established by alum, whereas the animals receiving the primary immunization with HBsAg/CpG ODN and later boosted with HBsAg/alum maintained their Th1 bias, even after the boost with alum. These data suggest that CpG ODN have the ability to augment both humoral and cell mediated immune responses and override the Th2 bias created by alum, even in very young animals, which are known to have a Th2 biased immune system. (C) 2001 Federation of European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:65 / 71
页数:7
相关论文
共 49 条
[1]   Neonatal administration of IL-12 enhances the protective efficacy of antiviral vaccines [J].
Arulanandam, BP ;
Mittler, JN ;
Lee, WT ;
O'Toole, M ;
Metzger, DW .
JOURNAL OF IMMUNOLOGY, 2000, 164 (07) :3698-3704
[2]  
Ballas ZK, 1996, J IMMUNOL, V157, P1840
[3]   Partial correction of the TH2/TH1 imbalance in neonatal murine responses to vaccine antigens through selective adjuvant effects [J].
Barrios, C ;
Brandt, C ;
Berney, M ;
Lambert, PH ;
Siegrist, CA .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (11) :2666-2670
[4]   Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: Predominance of a Th2-biased pattern which persists after adult boosting [J].
Barrios, C ;
Brawand, P ;
Berney, M ;
Brandt, C ;
Lambert, PH ;
Siegrist, CA .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (07) :1489-1496
[5]   Genetic regulation of commitment to interleukin 4 production by a CD4+ T cell-intrinsic mechanism [J].
Bix, M ;
Wang, ZE ;
Thiel, B ;
Schork, NJ ;
Locksley, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (12) :2289-2299
[6]  
Bomford R, 1998, DEV BIOL STAND, V92, P13
[7]   CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies [J].
Chu, RS ;
McCool, T ;
Greenspan, NS ;
Schreiber, JR ;
Harding, CV .
INFECTION AND IMMUNITY, 2000, 68 (03) :1450-1456
[8]   Induction of TH1 and TH2 CD4+ T cell responses: The alternative approaches [J].
Constant, SL ;
Bottomly, K .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :297-322
[9]   Immunology - Asthma: An epidemic in the absence of infection? [J].
Cookson, WOCM ;
Moffatt, MF .
SCIENCE, 1997, 275 (5296) :41-42
[10]  
Cowdery J, 1996, J IMMUNOL, V156, P4570